US Representative

Bruce Westerman 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 4)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB340

Introduced
1/12/23  
Refer
1/12/23  
Report Pass
10/19/23  
Hamas International Financing Prevention Act This bill imposes sanctions targeting Hamas, the Palestinian Islamic Jihad, and any affiliate or successor groups. The President must periodically report to Congress a list of each foreign person (individual or entity) that knowingly provides significant support or services to or is involved in a significant transaction with a senior member or supporter of the targeted groups. The President must impose two or more sanctions on the named persons. Specifically, the person may be (1) denied credit and services from the Export-Import Bank, (2) barred from purchasing certain controlled defense articles, (3) denied exports of items on the U.S. Munitions List, (4) prevented from receiving exports of certain goods or technology controlled for national security reasons, (5) prohibited from receiving financing of more than $10 million from any U.S. financial institution, or (6) subject to property-blocking restrictions. The President must periodically report to Congress a list of foreign governments that have repeatedly provided material support for the targeted groups' terrorist activities. The President shall bar these governments from receiving for one year (1) U.S. assistance, or (2) exports of controlled munitions. The Department of the Treasury must instruct U.S. leadership of international financial institutions to oppose providing assistance to an identified government for one year. The bill provides for certain exceptions and waivers, such as for transactions that would serve U.S. national interests. The President must report to Congress and periodically provide briefings on other specified topics related to the targeted groups, such as where these groups secure financing and surveillance equipment.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3406

Introduced
5/17/23  
Stop TSP ESG Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3407

Introduced
5/17/23  
Empowering Law Enforcement Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3413

Introduced
5/17/23  
Refer
5/17/23  
Refer
5/17/23  
Refer
5/18/23  
AM Radio for Every Vehicle Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3433

Introduced
5/17/23  
Refer
5/17/23  
Refer
5/19/23  
Report Pass
9/18/24  
Give Kids a Chance Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3561

Introduced
5/22/23  
Refer
5/22/23  
PATIENT Act of 2023 Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3635

Introduced
5/24/23  
Refer
5/24/23  
Save Rural Hospitals Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3702

Introduced
5/25/23  
Access Technology Affordability Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3774

Introduced
5/31/23  
Refer
5/31/23  
Report Pass
10/19/23  
SHIP Act Stop Harboring Iranian Petroleum Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3952

Introduced
6/9/23  
Refer
6/9/23  
To limit the flags that may be flown over a facility of the Department of Veterans Affairs.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4261

Introduced
6/21/23  
Refer
6/21/23  
ARC Act of 2023 Amputation Reduction and Compassion Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4278

Introduced
6/22/23  
Refer
6/22/23  
Refer
7/10/23  
Restore VA Accountability Act of 2023 Restore Department of Veterans Affairs Accountability Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4293

Introduced
6/22/23  
American Farmers Feed the World Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB431

Introduced
1/20/23  
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.